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Abstract Gamma-glutamyltransferase activity, genes tran- 
scripts and differentiation by all-trans retinoic acid have been 
investigated in cultured HL-60, U937 and K562 cells. Acquisition 
of morphological and functional characteristics confirmed the 
terminal differentiation of HL-60 and U937 cells. Ali-trans reti- 
noic acid increased gamma-glutamyltransferase ctivity in a cell 
type- and time-dependent manner. Treatments with all-trans reti- 
noic acid isomers and structurally analogs showed that only reti- 
noids with carboxylic acid group were able to induce enzyme 
activity in terminal differentiated cells. Additionally, the analysis 
of gamma-glutamyltransferase genes transcription products dem- 
onstrated clearly that, both in untreated and in RA treated cells, 
only mRNA type I transcribed from the gene 6, was expressed. 
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I. Introduction 
Gamma-glutamyltransferase (GGT, EC 2.3.2.2), a glycosyl- 
ated plasma membrane nzyme, is one of the key enzymes 
involved in glutathione (GSH) metabolism, GSH-detoxifica- 
tion pathway and other metabolic processes including the con- 
version of leukotriene C4 to leukotriene D4 [1,2]. GGT expres- 
sion is regulated by cytokines, growth factors, glucocorticoids 
and several xenobiotics [3 5]. The relative xpression of GGT 
genes is not well established yet, however, Courtay et al. [6] 
reported that GGT genes are expressed in several tissues in a 
specific manner. Several blood cells and their hematopoietic 
precursors express GGT, but only little is known regarding 
the significance and the regulation of this enzyme, especially 
during normal or pathological hematopoiesis. The particular 
plasma membrane localization of GGT makes possible its im- 
plication in events timulated by hematopoietic factors leading 
to proliferation and differentiation. Indeed, a novel role for 
GGT in the signal transduction pathway induced by hemato- 
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poietic cytokines, especially colony stimulating factors, has 
been described [3]. 
Retinoids, a group of naturally and synthetic molecules 
structurally related to vitamin A exert profound effects on the 
growth and differentiation f a wide variety of cells and tissues 
[7]. Direct antiproliferative effects of retinoic acid (RA) were 
observed in various cells such as F9 teratocarcinoma cells and 
HL-60 or U937 myeloid cells [8-10] concomitantly to differen- 
tiation and reversion of malignant phenotypes. Cell maturation 
often heralds the acquisition of differentiation markers. How- 
ever, the majority of these markers are not specific for one 
particular mature phenotype. Novogrodsky et al. [11] suggested 
that the surface localization of GGT and the relatively easier 
determination f its activity should make this enzyme useful as 
a surface marker for normal and neoplastic lymphoid cells in 
various stages of differentiation. However, the role and the 
expression of GGT in normal and pathological hematopoietic 
cells have not been clearly elucidated. In addition, no informa- 
tion is available on the effect of RA on GGT expression in 
established hematopoietic cell lines. Tsao and Batist, demon- 
strated that RA induces GGT expression i  a dose- and time- 
dependent manner in rat epithelial cells [12]. Additionally GGT 
is induced by RA in cultured rat osteoblasts (UMR 106) [13] 
and in cerebral endothelial cells (CR3) [14]. GGT activity is also 
induced in KG- I cells stimulated by hematopoietic growth 11to- 
tots, supporting an eventual role lk~r GGT in the cellular events 
occuring in myeloid cells response to hematopoietic growth 
factors [3]. 
The purpose of this work was to study the ability ofal l -trans 
retinoic acid to affect GGT genes expression and enzyme activ- 
ity in HL-60, K562 and U937 cell lines. 
2. Materials and methods 
2.1. (2,ll lines and culture conditions 
The human leukemic HL-60 (promyelocytic cells), K562 (early my_ 
eloid cells) and U937 (promonocytic cells) were from the European 
Collection of Animal Cell Cultures. The cells were grown in RPMI- 
1640 medium (Gibco-BRL, France) supplemented with 10% (v/v) heat- 
inactivated fetal calf serum (Boehringer-Mannheim, France), 1% (v/v) 
antibiotic-antimycotic (Gibco-BRL, France) and 2 mM L-glutamine 
(Gibco-BRL, France). Cultures were maintained at37°C in a humidi- 
fied atmosphere ofair/CO2 (95% :5%). 
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Abbreviations. GGT, gamma-glutarnyltransferase; PBS, phosphate- 
buffered saline; RA, all-trans retinoic acid; DMSO, dimethylsulfoxide: 
NBT, nitro-blue-tetrazolium; TPA, 12-0-tetradecanoylphorbol- 13-ace- 
tate; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro- 
mide); APL, acute promyelocytic leukemia; ALL, acute lymphoblastic 
leukemia: AML, acute myeloid leukemia; MDS, myelodysplasic yn- 
drom. 
2.2. Drug treatment induced dif/erentiation 
The retinoids tretinoin (all-wans retinoic acid)~ isotretinoin (13-cis- 
retinoic acid),  acitretin (all-trans-9-(methoxy-2,3~6-trimethyl 
phenyl)3,7-dimethyl-2,4,6,8-non-atetraecanoic acid), RO 13-7410 
(p-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtylt propenyl] 
benzoic acid), RO 13-6307 ([all-E]-3-methyl-7-(5,6,7,8-tetrahydro- 
5,5,8,8-tetramethyl-2-naphtyl)-2A,6-octatrienoic acid) were kindly pro- 
vided by Dr. Schneider F. (Hoffman-La Roche, Basel, Switzerland). 
They were initially dissolved in ethanol (Merck, France) to obtain 10 
mM stock solutions, stored in the dark at -20°C, and then diluted in 
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medium to obtain appropriate final concentrations. Maximum concen- 
tration of ethanol in the culture (< 0,1%) did not influence cell growth, 
differentiation or GGT activity. Following treatment, he cells (pro- 
tected from light) were harvested by centrifugation (5 rain, 400 x g) and 
cell pellets were washed twice with PBS (Eurolab, France) before stor- 
ing at -80°C until use. 
2.3. Enzyme assay 
GGT activity was determined in the cell pellets treated with 0,1% 
(v/v) Triton X-100 (Sigma, France) and incubated on ice for 30 minutes. 
The cell homogenates were used for GGT activity determination with 
6 mM L-?'-glutamyl-3-carboxy-4-nitroanilide (Boehringer-Mannheim, 
France) as a donor substrate and 150 mM glycyl-glycine (Merck, 
France) as the aceeptor substrate in 0,1 M Tris-HC1 pH 6.8 [15]. GGT 
activity was expressed as mU/mg proteins corresponding to nmoles/ 
min/mg proteins. Proteins were determined as described by Lowry et 
al. [16] using bovine serum albumine (Sigma, France) as a standard. 
2.4. Assessment of differentiation and cell proliferation 
Reduction of Nitro-blue-tetrazolium (NBT) (Sigma, France), a typi- 
cal marker of myelomonocytic differentiation was assayed colorimetri- 
cally as reported by Kasukabe t al. [17]. 200/tl of cell suspension (106 
cells) were incubated at 37°C, for 2 h with an equal volume of a solution 
containing 1 mg/ml NBT and 100 ng/ml TPA (Sigma, France). The 
reaction was stopped by addition of 50/11 HC1 (1 M final concentra- 
tion). The blue/black formazan precipitate obtained, was solubilized in 
DMSO and the absorbance was determined at 540 nm. 
Cell proliferation was assayed by MTT test according to Page et al. 
[18]. Briefly, 20 ktl of MTT solution (5 mg/ml in PBS) (Sigma, France) 
were added to 200/11 of cell suspension and the mixtures were incubated 
at 37°C in 96 well plate dish for 4 hours. After centrifugation, the 
formazan precipitates were dissolved in DMSO and absorbances were 
determined at 540 nm. Results are expressed as percentage of growth 
inhibition according to untreated cells. 
2.5. Cell adhesion 
Cell adhesion was assayed as described by Baud et al. [19]. Briefly, 
after treatment, nonadherent cells were harvested by centrifugation, 
washed twice with PBS and solubilized in 3% (w/v) SDS. Resting adher- 
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Fig. 1. Dose-dependent effect of retinoic acid treatment on GGT activ- 
ity in HL-60, U937 and K562 cell lines. Cells were treated uring 48 
hours with various concentrations of RA under conditions described 
in section 2. GGT is expressed as a percentage of control values which 
were 40.55 _+ 2.50, 71.90 + 4.50 and 16.95 _+ 3.50 mU/mg for HL-60 
(e), U937 (©) and K562 (m) cells, respectively. The results represent the 
means + S.D. of three separate measurements. 
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Fig. 2. Time course of GGT activity during retinoic acid treatment. 
U937 (o) and HL-60 (e) were treated waith 1/IM RA and K562 (m) 
cells with 2.5/~M RA. GGT is expressed as percentage ofcontrol values 
indicated in Fig. 1. The results represent the means + S.D. of three 
separate measurements. 
ent cells were washed with PBS and scraped directly in 3% SDS. 
Absorbance at 280 nm of solubilized cell pellets from both nonadherent 
and adherent cells were then measured. Results are expressed as a 
percentage of adherent cells calculated from the ratio between A2s0nm 
of adherent cells and the sum of A280nrn of adherent and non-adherent 
cells. 
2.6. RT-PCR method and analysis of amplified products 
Total RNA was isolated from untreated and treated HL-60, K562 
and U937 cells using the guanidium thiocyanate method described by 
Chomczynski and Sacchi [20]. 5/lg of RNA were subjected to reverse 
transcription using MMLV-reverse transcriptase (Gibco-BRL, France) 
according to the experimental procedure described by the manufac- 
turer. This was followed by standard PCR according to Courtay et al. 
[6] and using two probes: Amp 1 (5'-AATGGATGACTTCAGCTCT- 
3') and Amp 2 (5'-TCTACAACCTCTGGTTCGGCT-Y) which repre- 
sent the 5' and 3' primers, respectively (Eurogentec, Belgium). The 
presence of different GGT genes transcripts in amplified products was 
detected by Southern blot and hybridization with corresponding 
[y-32P]ATP-labeled oligonucleotides probes according to Courtay et al. 
[6]. The oligonucleotides probes used, specific for gene 1, 3 and 6, 
respectively, were: 
Amp 5 (5'-CTGATATGTGTCACCCCTTTTCT-3') 
Mut 3 (5'-CTCTTGTCCATGTGCCTGAC-3') 
Mut 6 (5'-CCAACGAGTTTGGGGTACCC-3') 
Optimal washing temperatures were: 55°C, 67°C and 65°C for re- 
spectively Amp 5, Mut 3 and Mut 6 probes (Eurogentec, Belgium). 
3. Results  
3.1. Effect of  retinoic acid on cell proliferation, differentiation 
and cell adhesion 
It is well known that HL-60 and U937 cells treated with 
All-trans retinoic acid differentiate fficiently toward neutro- 
phils and macrophages, respectively [9,10]. By contrast, RA did 
not induce differentiation of K562 cells [21]. We, first, examined 
the effect of RA on cell growth, cell adhesion and acquisition 
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Fig. 3. Autoradiography of Southern blot hybridization of amplified 
RT-PCR transcripts of GGT genes. Cells were treated uring 96 hours, 
under conditions described in section 2, before total RNA extraction. 
PCR products, from GGT genomic 1.6 Kb Bgl II fragment described 
by Courtay et al. [6] serve as positive controls. They are indicated by 
337 pb fragments corresponding to gene 1 (lane 7A), gene 3 (lane 7B) 
and gene 6 (lane 7C). RNAs used in this study were isolated from U937 
control cells (lane 1), 1 ,uM RA treated U937 cells (lane 2), HL-60 
control cells (lane 3), 1 ,uM RA treated HL-60 cells (lane 4), K562 
control cells (lane 5), 2.5/IM RA treated K562 cells (lane 6). Hybrida- 
tion was perfl)rmed with the following probes: A, Mut 3 ; B, Amp 5 and 
C, Mut 6. 
of NBT reduction capacity by treated cells. In both HL-60 and 
K562 treated cells, a slight growth inhibition (6%) was observed 
when the cells were treated with 1/.tM RA. The percentage of 
growth inhibition increased with the concentration of drug and 
reached 15% and 30% values for the HL-60 and K562 cells, 
respectively, when treated with 10/,tM RA. More pronounced 
growth inhibition, reaching 45% was observed for U937 cells 
treated with increasing doses of RA ranging from 0,1 to 10/IM. 
Functional differentiation process was followed by the eval- 
Table l 
Influence of RA treatment on N BT reducing activity and cell adhesion 
NBT reducing activity Cell adherence 
(A540 nm/106 cells) (%) 
HL-60 Control 0.25 _+ 0.01 2.05 + 0.10 
RA (1 tIM) 0.82_+0.02 26.45+2.50 
U937 Control 0.11 _+0.10 2.40_+0.15 
RA (l yM) 0.62_+0.15 28.00_+3.20 
K562 Control 1.16 -+ 0.20 2.40 + 0.20 
RA(2.5uM) 1.13 + 0.18 2.70+0.18 
Cells were cultured under conditions described in section 2. RA was 
added to the culture medium, and both control and treated cells were 
cultured during 4 days before performing NBT reducing activity and 
cell adhesiveness measurement. NBT activity was performed for 10 6 
cells and results are expressed as  A540n m. Cell adhesiveness was evalu- 
ated by cell scraping and measurement of A_,80nm of SDS cell lysates. 
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Table 2 
Effect of retinoids on GGT activity in HL-60 and U937 cells 
GGT activity (mU/mg protein) 
Retinoids HL-60 cells U937 cells 
Control 39.60 + 5.00 70.50 -+ 5.00 
Retinoic acid 142.20 _+ 6.00 105.75 _+ 5.00 
RO 13-6307 143.50 + 3.00 122.80 _+ 3.00 
Isotretinoine 134.68 + 5.00 102.20 _+ 9.00 
RO 13-7410 130.68 + 2.00 190.35 +_ 6.00 
Acitretine 99.00 _+ 9.00 1(/9.27 + 8.00 
RO 40-8757 50.88 _+ 6.00 66.97 _+ 15.00 
Cells were exposed to 1/IM of several retinoids during 2 days and GGT 
activity was measured as described in section 2. Results represent 
mean + S.D. of three separate measurements. 
uation of NBT reducing activity of untreated and RA treated 
cells. Cells were incubated with RA during 4 days at the final 
concentrations of 1/~M for HL-60 and U937 cells, and 2.5 yM 
for K562 cells. Table 1 shows NBT reduction in terms of varia- 
tions in the absorbances at 540 nm. Data obtained showed that 
RA induced an increase of NBT reduction in both HL-60 and 
U937 cells, stimulated with TPA, as described by Breitman et 
al. [9] and Olsson et al. [10]. By contrast, NBT reduction activity 
was not modified in RA-K562 treated cells. 
Concomitantly to cell growth inhibition, we observed an 
increase in cell adhesiveness of HL-60 and U937 RA treated 
cells (Table 1 ). By contrast, RA treatment did not affect K562 
cell adherence, even at a higher concentration (10/JM). This is 
probably because of the lack in differentiation of these cells 
after RA treatment. 
3.2. Ef[bct o/RA on GGT specific activity 
In order to study the variation of GGT activity after cell 
differentiation, we treated our cell lines with progressively 
increasing doses of RA during 48 hours and measured GGT 
activity in both treated and control cells. Fig. 1 shows that the 
exposure of cells to various concentrations of RA during 48 
hours leads to a cell type-specific modulation of GGT activity. 
A significant increase of GGT activity was observed in HL-60 
and U937 RA treated cells, whereas GGT activity was slightly 
modified in K562 RA treated cells. The highest increase of 
GGT activity was obtained tSr RA concentrations ranging 
from 0.1 ,uM to 5 / IM for both HL-60 and U937 cells. Treat- 
ment with higher concentrations of RA did not increase GGT 
activity in these two cell lines. 
So far, time-course xperience was choosen to describe the 
effect of RA on GGT activity in the three cell lines K562, HL-60 
and U937, during various periods of treatment. GGT activity 
increases in a time dependent manner (Fig. 2). After 72 hours 
treatment, GGT induction was about 180% and 305% of con- 
trol values for U937 and HL-60 cells, respectively. In K562 
cells, GGT activity increases lightly and the maximal induction 
(130%) was observed after 48 hours of treatment. 
The effect of five structural analogs of RA was then studied. 
Table 2 summarizes their effects on GGT activity in HL-60 and 
U937 cells. In comparison to RA effect, similar results were 
obtained when the HL-60 and U937 cells were treated with 
1 ¢tM RO 13-6307 and isotretinoin. Lower induction effect was 
observed when these cells were treated with acitretin and RO 
40 8757. In contrast, RO 13 7410 treatment of U937 cells 
resulted in an induction of 270%, which was higher than that 
observed after RA treatment. 
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3.3. GGT gene expression in RA treated cells 
RT-PCR followed by hybridization with specific oligonucle- 
otides probes was performed in order to characterize GGT 
genes expressed in studied cells. In all studied samples, a PCR 
product of 218 pb, corresponding to all possible GGT mRNAs 
was observed on an ethidium-bromide stained gel (data not 
shown). Hybridization experiments (Fig. 3) using specific 
probes for the GGT genes 1, 3 and 6 demonstrated that U937, 
HL-60 and K562 cells express only gene 6. Treatment of the 
cells with 1/,tM RA did not result in the activation of transcrip- 
tion of any other gene than that expressed in untreated cells. 
4. Discussion 
GGT is one of the numerous enzymes upposed to be regu- 
lated during the differentiation process [11]. Actually, not enough 
data concerning GGT expression during hematopoietic cell 
differentiation are available. However, some previous tudies 
showed that hematopoietic growth factors including some cy- 
tokines, induce GGT activity and mRNA level in KG- 1 cell line 
[3]. Additionally, RA enhances GGT activity in several cells 
[12-14]. Retinoids capable of inducing cellular maturation i  
vitro have been proposed as therapeutical gents in diseases 
such as acute promyelocytic leukemia nd myelodysplasic yn- 
drom [22] which are characterized by a block in hematopoietic 
differentiation. Our results demonstrated that HL-60 and U937 
treated with RA differentiated into mature cells. Concomi- 
tantly to cell differentiation, GGT activity was induced after 
RA treatment suggesting a typical regulation of this enzyme 
during differentiation process. In contrast, K562 cells which are 
known to lack in differentiation after RA treatment [21], did 
not exhibit a marked modification i GGT activity. In addition 
to RA, a series of retinoids, structurally apparented, have been 
studied for their ability to induce GGT activity in HL-60 and 
U937 cells. All retinoids tested, except RO 40-8757, induced 
GGT activity in these cells. However, there was a smaller in- 
crease in GGT activity in U937 cells which are known to be less 
sensitive than HL-60 cells [23]. Our results showed that only 
retinoids containing a terminal carboxylic acid group, such as 
tretinoin, RO 13-6307, isotretinoin, RO 13-7410 and acitretin, 
were able to induce GGT activity. Surprisingly, these retinoids 
are known to induce HL-60 and U937 cell differentiation [23]. 
Thus, our data clearly demonstrated that GGT induction in 
retinoids-treated HL-60 and U937 cells, seems to be a general 
phenomenon associated with the functional maturation and 
differentiation of both the promyelocytic and promonocytic 
studied cell lines. 
GGT is encoded by a multigenic family of at least seven 
genes. Courtay et al. [6] reported that five GGT genes are 
expressed in man, in a tissue-restricted manner, suggesting that 
their products can exhibit distinct functions in various tissues. 
Gene 6 seems to be ubiquitously expressed in all tested tissues 
including lymphocytes and bone marrow [6]. By contrast, gene 
1 was expressed only in placenta, sigmoid, thyroid and lung, 
while gene 3 expression was detected only in thyroid, sigmoid 
and placenta. Our purpose was to characterize gene 1, 3 and 
6 transcripts incontrol and RA-treated cells. From our results, 
it became clear that only GGT gene 6 was expressed in HL-60, 
U937 and K562 cells, and that RA-induced GGT activity in 
both U937 and HL-60 cells, is related solely to the expression 
of gene 6. 
In conclusion, we clearly demonstrated that GGT activity is 
induced uring U937 and HL-60 cell differentiation process, by 
all-trans retinoic acid and some structurally related retinoids. 
However, it is at present unclear if the increased GGT activity 
level is due to increased transcription or increased post tran- 
scriptional stabilization of the GGT mRNAs. We do not know 
the significance and the mechanism by which RA differentially 
induced ifferentiation f HL-60 and U937 cells, but the HPLC 
analysis of methylated cytosine showed an hypomethylation of 
genomic DNA in these two cell lines during RA treatment (data 
not shown). Future studies to determine the GGT-specific 
genes methylation profils in these cells should clarify mecha- 
nisms and significance of its induction during cell proliferation 
and differentiation. 
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